全文获取类型
收费全文 | 3308篇 |
免费 | 165篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 50篇 |
妇产科学 | 37篇 |
基础医学 | 397篇 |
口腔科学 | 55篇 |
临床医学 | 174篇 |
内科学 | 877篇 |
皮肤病学 | 50篇 |
神经病学 | 318篇 |
特种医学 | 163篇 |
外科学 | 467篇 |
综合类 | 7篇 |
预防医学 | 93篇 |
眼科学 | 69篇 |
药学 | 292篇 |
中国医学 | 14篇 |
肿瘤学 | 344篇 |
出版年
2023年 | 22篇 |
2022年 | 10篇 |
2021年 | 58篇 |
2020年 | 39篇 |
2019年 | 58篇 |
2018年 | 77篇 |
2017年 | 64篇 |
2016年 | 77篇 |
2015年 | 91篇 |
2014年 | 114篇 |
2013年 | 118篇 |
2012年 | 187篇 |
2011年 | 231篇 |
2010年 | 121篇 |
2009年 | 97篇 |
2008年 | 176篇 |
2007年 | 226篇 |
2006年 | 257篇 |
2005年 | 174篇 |
2004年 | 205篇 |
2003年 | 178篇 |
2002年 | 179篇 |
2001年 | 82篇 |
2000年 | 67篇 |
1999年 | 67篇 |
1998年 | 25篇 |
1997年 | 19篇 |
1996年 | 22篇 |
1995年 | 13篇 |
1994年 | 17篇 |
1993年 | 14篇 |
1992年 | 47篇 |
1991年 | 46篇 |
1990年 | 39篇 |
1989年 | 30篇 |
1988年 | 34篇 |
1987年 | 22篇 |
1986年 | 31篇 |
1985年 | 22篇 |
1984年 | 19篇 |
1983年 | 19篇 |
1982年 | 5篇 |
1980年 | 6篇 |
1979年 | 16篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1974年 | 5篇 |
1971年 | 9篇 |
1970年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有3485条查询结果,搜索用时 187 毫秒
1.
Eriko Yanagida Hiroaki Miyoshi Mai Takeuchi Noriaki Yoshida Kazutaka Nakashima Kyohei Yamada Takeshi Umeno Yasumasa Shimasaki Takuya Furuta Masao Seto Koichi Ohshima 《Hematological oncology》2020,38(5):680-688
The interaction of CD47 and signal-regulatory protein alpha (SIRPα) induces “don't eat me signal”, leading suppression of phagocytosis. This signal can affect the clinical course of malignant disease. Although CD47 and SIRPα expression are associated with clinicopathological features in several neoplasms, the investigation for adult T-cell leukemia/lymphoma (ATLL) has not been well-documented. This study aimed to declare the association between CD47 and SIRPα expression and clinicopathological features in ATLL. We performed immunostaining on 73 biopsy samples and found that CD47 is primarily expressed in tumor cells, while SIRPα is expressed in non-neoplastic stromal cells. CD47 positive cases showed significantly higher FoxP3 (P = .0232) and lower CCR4 (P = .0214). SIRPα positive cases presented significantly better overall survival than SIRPα negative cases (P = .0132). SIRPα positive cases showed significantly HLA class I (P = .0062), HLA class II (P = .0133), microenvironment PD-L1 (miPD-L1) (P = .0032), and FoxP3 (P = .0229) positivity. In univariate analysis, SIRPα expression was significantly related to prognosis (Hazard ratio [HR] 0.470; 95% confidence interval [CI] 0.253-0.870; P = .0167], although multivariate analysis did not show SIPRα as an independent prognostic factor. The expression of SIRPα on stromal cells reflects activated immune surveillance mechanism in tumor microenvironment and induce good prognosis in ATLL. More detailed studies for gene expression or genomic abnormalities will disclose clinical and biological significance of the CD47 and SIRPα in ATLL. 相似文献
2.
3.
Yoshinori Yanai Takeo Kosaka Kohei Nakamura Eriko Aimono Kazuhiro Matsumoto Shinya Morita Shuji Mikami Hiroshi Nishihara Mototsugu Oya 《Cancer science》2020,111(12):4652
Cyclin‐dependent kinase 12 (CDK12), one of the key factors associated with DNA damage response pathways, is located on chromosome 17 proximal to Erb‐B2 receptor tyrosine kinase 2 (ERBB2). In this report, CDK12 and ERBB2 coamplification was detected by targeted next‐generation sequencing in two urothelial carcinomas. The staining intensity of the CDK12 and human epidermal growth factor receptor‐2 proteins was associated with the prognosis of each urothelial carcinoma case. Our results suggest that CDK12 coamplification with ERBB2 might be associated with tumor aggressiveness and contribution to cancer pathogenesis. Therapies targeting CDK12 should be developed for these patients. 相似文献
4.
Real Time Three‐Dimensional Echocardiographic Evaluations of Fetal Left Ventricular Stroke Volume,Mass, and Myocardial Strain: In Vitro and In Vivo Experimental Study 下载免费PDF全文
5.
Yasushi Yamasaki Keita Harada Shumpei Yamamoto Eriko Yasutomi Shotaro Okanoue Mami Hirai Shohei Oka Yuka Obayashi Hiroyuki Sakae Kenta Hamada Toshihiro Inokuchi Hideaki Kinugasa Yuusaku Sugihara Masahiro Takahara Takehiro Tanaka Sakiko Hiraoka Yoshiro Kawahara Hiroyuki Okada 《Digestive endoscopy》2020,32(5):791-800
6.
7.
8.
9.
Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation 下载免费PDF全文
Mutsumi Nishida Akio Shigematsu Megumi Sato Yusuke Kudo Satomi Omotehara Tatsunori Horie Takahito Iwai Tomoyuki Endo Akihiro Iguchi Hitoshi Shibuya Kanako Hatanaka Chikara Shimizu Takanori Teshima 《Clinical transplantation》2015,29(8):697-704
Gastrointestinal graft‐versus‐host disease (GI‐GVHD) is a major and life‐threatening complication of hematopoietic stem cell transplantation (HSCT). This study evaluated the efficacy of ultrasonography (US) for assessing and monitoring GI‐GVHD. GI tract was evaluated by US in 81 patients. US findings were positive in 43 patients, including 11 false positive, and negative in 38 patients. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of US for the diagnosis of GI‐GVHD were 100%, 78%, 74%, 100%, and 86%, respectively. Diffuse wall thickening of the ileum was the most frequent finding in patients with GI‐GVHD. Severity of GI‐GVHD was correlated with the thickness of internal low echoic layer of the wall, the echogenicity of mesenteric fat tissue, and the intensity of Doppler signaling. We classified US findings of GI‐GVHD into four US grades. There was a significant correlation between clinical stage of GI‐GVHD and the US grade. These ultrasonographic abnormalities were improved with clinical improvement of GI‐GVHD upon treatment. Thus, US is an effective and efficient non‐invasive means of identifying the extent and severity of GI‐GVHD and monitoring response to treatment. 相似文献
10.
Eriko Kikuchi Takayasu Mori Moko Zeniya Kiyoshi Isobe Mari Ishigami-Yuasa Shinya Fujii Hiroyuki Kagechika Tomoaki Ishihara Tohru Mizushima Sei Sasaki Eisei Sohara Tatemitsu Rai Shinichi Uchida 《Journal of the American Society of Nephrology : JASN》2015,26(7):1525-1536
Upon activation by with-no-lysine kinases, STE20/SPS1-related proline–alanine-rich protein kinase (SPAK) phosphorylates and activates SLC12A transporters such as the Na+-Cl− cotransporter (NCC) and Na+-K+-2Cl− cotransporter type 1 (NKCC1) and type 2 (NKCC2); these transporters have important roles in regulating BP through NaCl reabsorption and vasoconstriction. SPAK knockout mice are viable and display hypotension with decreased activity (phosphorylation) of NCC and NKCC1 in the kidneys and aorta, respectively. Therefore, agents that inhibit SPAK activity could be a new class of antihypertensive drugs with dual actions (i.e., NaCl diuresis and vasodilation). In this study, we developed a new ELISA-based screening system to find novel SPAK inhibitors and screened >20,000 small-molecule compounds. Furthermore, we used a drug repositioning strategy to identify existing drugs that inhibit SPAK activity. As a result, we discovered one small-molecule compound (Stock 1S-14279) and an antiparasitic agent (Closantel) that inhibited SPAK-regulated phosphorylation and activation of NCC and NKCC1 in vitro and in mice. Notably, these compounds had structural similarity and inhibited SPAK in an ATP-insensitive manner. We propose that the two compounds found in this study may have great potential as novel antihypertensive drugs. 相似文献